Royal Philips, the parent company of Philips Healthcare, said that it has no intention of acquiring robotic catheterization developer Corindus Vascular Robotics.
Siemens Healthineers last week reached an agreement to buy Corindus in a deal valued at $1.1 billion.
Philips currently holds a 12.8% stake in Corindus, making Philips the second-largest shareholder. Nonetheless, the company affirmed that it did not and does not plan to make a counter offer to the Siemens agreement.
